Apyx Medical Corp Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Apyx Medical Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Apyx Medical Corp Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$4.7M, a 1.6% decline year-over-year.
  • Apyx Medical Corp Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$28.4M, a 87.7% decline year-over-year.
  • Apyx Medical Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$18.7M, a 19.3% increase from 2022.
  • Apyx Medical Corp annual Net Income (Loss) Attributable to Parent for 2022 was -$23.2M, a 52.8% decline from 2021.
  • Apyx Medical Corp annual Net Income (Loss) Attributable to Parent for 2021 was -$15.2M, a 27.5% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$28.4M -$4.7M -$74K -1.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 -$28.4M -$6.56M -$5.56M -560% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$22.8M -$7.58M -$4.09M -118% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$18.7M -$9.61M -$3.56M -58.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 -$15.2M -$4.63M +$1.14M +19.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 -$16.3M -$994K +$4.43M +81.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$20.7M -$3.48M +$2.46M +41.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$23.2M -$6.05M -$4.05M -202% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$19.1M -$5.76M -$1.54M -36.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$17.6M -$5.43M -$1.38M -34.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$16.2M -$5.95M -$1.04M -21.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$15.2M -$2M -$476K -31.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 -$14.7M -$4.22M -$494K -13.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$14.2M -$4.05M +$644K +13.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$14.8M -$4.9M -$2.95M -151% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$11.9M -$1.53M +$3.86M +71.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 -$15.8M -$3.73M +$642K +14.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$16.4M -$4.69M -$352K -8.11% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$16M -$1.95M +$3.66M +65.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$19.7M -$5.39M -$3.51M -187% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$16.2M -$4.37M -$72.8M -106% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $56.6M -$4.34M -$1.4M -47.7% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $58M -$5.61M -$4.67M -500% Jan 1, 2019 Mar 31, 2019 10-Q/A 2020-05-08
Q4 2018 $62.7M -$1.88M -$1.05M -128% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-31
Q3 2018 $63.8M $68.5M +$69.7M Jul 1, 2018 Sep 30, 2018 10-Q/A 2020-05-08
Q2 2018 -$5.94M -$2.94M -$1.63M -125% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$4.31M -$935K +$750K +44.5% Jan 1, 2018 Mar 31, 2018 10-Q/A 2020-05-08
Q4 2017 -$5.06M -$824K +$7.3M +89.9% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-31
Q3 2017 -$12.4M -$1.25M -$280K -29% Jul 1, 2017 Sep 30, 2017 10-Q/A 2020-05-08
Q2 2017 -$12.1M -$1.31M -$789K -152% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 -$11.3M -$1.69M +$259K +13.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$11.6M -$8.12M -$6.71M -476% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-14
Q3 2016 -$4.84M -$965K +$622K +39.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 -$5.46M -$519K +$978K +65.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 -$6.44M -$1.94M -$1.07M -122% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$5.37M -$1.41M +$4.04M +74.1% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-18
Q3 2015 -$9.41M -$1.59M +$1.39M +46.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-27
Q2 2015 -$10.8M -$1.5M -$1.53M -5262% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-02
Q1 2015 -$9.28M -$876K +$8.94M +91.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q4 2014 -$18.2M -$5.45M -$329K -6.42% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-18
Q3 2014 -$17.9M -$2.98M -$2.64M -773% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-18
Q2 2014 -$15.2M $29K +$1.15M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-18
Q1 2014 -$16.4M -$9.81M -$9.4M -2299% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-18
Q4 2013 -$6.99M -$5.13M -$5.41M -1898% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-27
Q3 2013 -$1.58M -$341K -$334K -4771% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-27
Q2 2013 -$1.25M -$1.12M -$1.27M -836% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-27
Q1 2013 $21K -$409K -$596K -319% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-27
Q4 2012 $617K $285K +$1.16M Oct 1, 2012 Dec 31, 2012 10-K/A 2014-05-08
Q3 2012 -$543K -$7K -$70K -111% Jul 1, 2012 Sep 30, 2012 10-K/A 2014-05-08
Q2 2012 -$473K $152K -$277K -64.6% Apr 1, 2012 Jun 30, 2012 10-K/A 2014-05-08
Q1 2012 -$196K $187K -$305K -62% Jan 1, 2012 Mar 31, 2012 10-K/A 2014-05-08
Q4 2011 $109K -$875K Oct 1, 2011 Dec 31, 2011 10-K 2013-04-01
Q3 2011 $63K +$59K Jul 1, 2011 Sep 30, 2011 10-K 2013-04-01
Q2 2011 $429K +$373K +666% Apr 1, 2011 Jun 30, 2011 10-K 2013-04-01
Q1 2011 $492K Jan 1, 2011 Mar 31, 2011 10-K 2013-04-01
Q3 2010 $4K* Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 $56K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.